Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Prepaid Assets (2020 - 2025)

Historic Prepaid Assets for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to $9.3 million.

  • PROCEPT BioRobotics' Prepaid Assets rose 4636.92% to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year increase of 4636.92%. This contributed to the annual value of $8.5 million for FY2024, which is 6215.23% up from last year.
  • PROCEPT BioRobotics' Prepaid Assets amounted to $9.3 million in Q3 2025, which was up 4636.92% from $7.5 million recorded in Q2 2025.
  • PROCEPT BioRobotics' Prepaid Assets' 5-year high stood at $9.3 million during Q3 2025, with a 5-year trough of $2.2 million in Q3 2021.
  • Its 5-year average for Prepaid Assets is $5.5 million, with a median of $5.0 million in 2024.
  • Its Prepaid Assets has fluctuated over the past 5 years, first soared by 15662.43% in 2021, then tumbled by 1557.89% in 2023.
  • PROCEPT BioRobotics' Prepaid Assets (Quarter) stood at $4.2 million in 2021, then surged by 45.57% to $6.2 million in 2022, then fell by 15.58% to $5.2 million in 2023, then surged by 62.15% to $8.5 million in 2024, then increased by 9.45% to $9.3 million in 2025.
  • Its Prepaid Assets was $9.3 million in Q3 2025, compared to $7.5 million in Q2 2025 and $8.0 million in Q1 2025.